Entities developing "operating rules" to make HIPAA administrative/financial transactions more uniform should not be compelled to address additional issues not mandated under the Accountable Care Act, according to testimony today in Washington.

The National Committee on Vital and Health Statistics, a federal advisory body, heard testimony from two organizations--CAQH and the National Council for Prescription Drug Programs--developing operating rules for specific transactions. "Additional topics have not been vetted fully by the entire industry and therefore must not be imposed on the entire industry," noted Lynne Gilbertson, vice president of standards development at NCPDP.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access